ADIL
Geode Capital Management’s Adial Pharmaceuticals ADIL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8K | Hold |
68,850
| – | – | ﹤0.01% | 4356 |
|
|
2025
Q1 | $43.7K | Buy |
68,850
+7,003
| +11% | +$4.44K | ﹤0.01% | 4224 |
|
|
2024
Q4 | $62.5K | Buy |
61,847
+16,381
| +36% | +$16.5K | ﹤0.01% | 4203 |
|
|
2024
Q3 | $45.4K | Buy |
45,466
+19,592
| +76% | +$19.6K | ﹤0.01% | 4283 |
|
|
2024
Q2 | $29.8K | Buy |
+25,874
| New | +$29.8K | ﹤0.01% | 4391 |
|
|
2023
Q3 | – | Sell |
-137,464
| Closed | -$28.6K | – | 4759 |
|
|
2023
Q2 | $28.6K | Hold |
137,464
| – | – | ﹤0.01% | 4607 |
|
|
2023
Q1 | $48.1K | Hold |
137,464
| – | – | ﹤0.01% | 4529 |
|
|
2022
Q4 | $29K | Hold |
137,464
| – | – | ﹤0.01% | 4709 |
|
|
2022
Q3 | $48K | Buy |
137,464
+1,575
| +1% | +$550 | ﹤0.01% | 4772 |
|
|
2022
Q2 | $182K | Buy |
135,889
+787
| +0.6% | +$1.05K | ﹤0.01% | 4323 |
|
|
2022
Q1 | $271K | Buy |
135,102
+5,775
| +4% | +$11.6K | ﹤0.01% | 4226 |
|
|
2021
Q4 | $349K | Buy |
129,327
+33,250
| +35% | +$89.7K | ﹤0.01% | 4224 |
|
|
2021
Q3 | $412K | Buy |
96,077
+7,831
| +9% | +$33.6K | ﹤0.01% | 4119 |
|
|
2021
Q2 | $225K | Buy |
88,246
+10,261
| +13% | +$26.2K | ﹤0.01% | 4302 |
|
|
2021
Q1 | $188K | Hold |
77,985
| – | – | ﹤0.01% | 4131 |
|
|
2020
Q4 | $132K | Hold |
77,985
| – | – | ﹤0.01% | 4006 |
|
|
2020
Q3 | $173K | Hold |
77,985
| – | – | ﹤0.01% | 3759 |
|
|
2020
Q2 | $108K | Hold |
77,985
| – | – | ﹤0.01% | 3828 |
|
|
2020
Q1 | $101K | Hold |
77,985
| – | – | ﹤0.01% | 3763 |
|
|
2019
Q4 | $187K | Hold |
77,985
| – | – | ﹤0.01% | 3817 |
|
|
2019
Q3 | $116K | Hold |
77,985
| – | – | ﹤0.01% | 3913 |
|
|
2019
Q2 | $131K | Hold |
77,985
| – | – | ﹤0.01% | 3892 |
|
|
2019
Q1 | $267K | Buy |
77,985
+64,404
| +474% | +$221K | ﹤0.01% | 3651 |
|
|
2018
Q4 | $69K | Buy |
+13,581
| New | +$69K | ﹤0.01% | 3932 |
|